Episode 025Relapsed Myeloma
An Additional New Hope - Understanding GPRC5D Treatment
4 December 2025
33:19
About This Episode
This episode introduces Talquetamab - a newly approved bispecific antibody for relapsed myeloma - explaining how it works, who it's for, and what side effects patients should expect and prepare for.